These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12632444)

  • 1. The diagnosis and prognosis of early arthritis: comment on the editorial by Scott.
    Visser H; Hazes JM
    Arthritis Rheum; 2003 Mar; 48(3):856-7; author reply 857-8. PubMed ID: 12632444
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott.
    van Venrooij WJ; van de Putte LB; van den Hoogen FH
    Arthritis Rheum; 2003 Mar; 48(3):857; author reply 857-8. PubMed ID: 12632446
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-citrulline antibodies in psoriatic patients with and without arthritis.
    Parodi A; Drosera M; Seriolo B; Barbieri L; Rebora A
    Acta Derm Venereol; 2005; 85(3):253-4. PubMed ID: 16040413
    [No Abstract]   [Full Text] [Related]  

  • 4. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.
    Saraux A; Berthelot JM; Devauchelle V; Bendaoud B; Chalès G; Le Henaff C; Thorel JB; Hoang S; Jousse S; Baron D; Le Goff P; Youinou P
    J Rheumatol; 2003 Dec; 30(12):2535-9. PubMed ID: 14719190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and prognostic significance of antibodies against citrullinated peptides].
    Schulze-Koops H; Manger B
    Dtsch Med Wochenschr; 2006 Feb; 131(6):269-71. PubMed ID: 16463231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis].
    Dubrous P; Gardet V; Hugard L
    Pathol Biol (Paris); 2005 Mar; 53(2):63-7. PubMed ID: 15708648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.
    Jansen TL; Bruyn GA
    J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273
    [No Abstract]   [Full Text] [Related]  

  • 8. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.
    Tedesco A; D'Agostino D; Soriente I; Amato P; Piccoli R; Sabatini P
    Autoimmun Rev; 2009 Jan; 8(3):233-7. PubMed ID: 18708166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticitrulline antibody assay specificity for rheumatoid arthritis: comment on the article by Schellekens et al.
    Berthelot JM; Saraux A
    Arthritis Rheum; 2000 Aug; 43(8):1901-2. PubMed ID: 10943885
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-citrulline antibodies in rheumatoid arthritis; diagnostic and prognostic values].
    Szmyrka-Kaczmarek M; Dziemianko I; Szechiński J
    Pol Arch Med Wewn; 2003 Aug; 110(2):915-20. PubMed ID: 14682232
    [No Abstract]   [Full Text] [Related]  

  • 11. Rheumatologic diagnostic serology: tests which test clinicians.
    Wong ML
    N Z Med J; 2004 Oct; 117(1203):U1095. PubMed ID: 15477919
    [No Abstract]   [Full Text] [Related]  

  • 12. The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis.
    Jansen LM; van Schaardenburg D; van der Horst-Bruinsma I; van der Stadt RJ; de Koning MH; Dijkmans BA
    J Rheumatol; 2003 Aug; 30(8):1691-5. PubMed ID: 12913923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
    J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in normals--the value of predicting rheumatoid arthritis.
    Dörner T; Hansen A
    Arthritis Res Ther; 2004; 6(6):282-4. PubMed ID: 15535841
    [No Abstract]   [Full Text] [Related]  

  • 15. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
    Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
    Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is assaying autoantibodies useful for diagnosing early rheumatoid arthritis?
    van Venrooij WJ; van de Putte LB
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):4-5. PubMed ID: 16932618
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
    Yalaoui S
    Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
    J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies against citrullinated proteins--a breakthrough in rheumatologic diagnostics].
    Rönnelid J; Klareskog L; Skogh T; Svensson B
    Lakartidningen; 2004 Dec; 101(50):4092-6. PubMed ID: 15631262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.